Home

Robert N Fried

CIK 1417952 · Chief Executive Officer · last filed 2026-07-08

Robert N Fried is a Chief Executive Officer who has filed 45 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider was granted $3.0K of NAGE on Jul 8, 2026. Across all open-market trades the lifetime net is +$423.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.30M

Companies

5

Total Filings

45

Lifetime Open-Market Net

$423.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NAGE Chief Executive Officer 1,072,833 $3.08 $3.30M $0 4 2026-07-08
Niagen Bioscience, Inc. (CDXC) Delisted Chief Executive Officer 1,067,315 $7.87 $8.40M $423.7K 28 2025-02-27
Fluent, Inc. (IDI) Delisted Director 318,671 — — $0 5 2016-06-03
Fluent, Inc. (IDI.WS) Delisted President & CEO — — — $0 2 2010-01-13
Ideation Acquisition Corp. (IDI.U) Delisted President & CEO 620,500 — — $0 1 2007-11-28

Recent Filings

45 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-08 NAGE Grant (A) +1,106 $3.0K EDGAR
2026-04-27 NAGE Exer (M) +20,000 $52.2K EDGAR
2026-02-24 NAGE Grant (A) — $0 EDGAR
2025-04-09 NAGE Exer (M) +66,667 $220.0K EDGAR
2025-02-27 Niagen Bioscience, Inc. (CDXC) Delisted Grant (A) — $0 EDGAR
2025-02-14 Niagen Bioscience, Inc. (CDXC) Delisted Grant (A) — $0 EDGAR
2024-02-23 Niagen Bioscience, Inc. (CDXC) Delisted Grant (A) — $0 EDGAR
2023-06-01 Niagen Bioscience, Inc. (CDXC) Delisted Buy (P) +7,000 $9.9K EDGAR
2023-02-17 Niagen Bioscience, Inc. (CDXC) Delisted Grant (A) — $0 EDGAR
2022-10-03 Niagen Bioscience, Inc. (CDXC) Delisted Buy (P) +80,000 $100.0K EDGAR
Showing 1–10 of 45
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.